CanNegev started due diligence with first optional portfolio company

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

NOV

2020

We have started our first due diligence with a very promising and exciting company. More opportunities are in our deal flow pipeline. Stay tuned….

We invite entrepreneurs and startups with medical cannabis related
innovations in the field of biotech, pharma, agtech, cleantech and foodtech to
present their initiative and be part of CanNegev – the home for medical
cannabis innovations.